Remedium Lifecare [REMLIFE] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Remedium Lifecare Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Remedium Lifecare Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Remedium Lifecare Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 6.54 67.11 Remedium Lifecare Ltd.
Price-to-Book Ratio 0.71 10.82 Remedium Lifecare Ltd.
Debt-to-Equity Ratio 1,033.81 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.03 4.63 Remedium Lifecare Ltd.
EV/EBITDA 206.57 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) 2.33% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 6.64% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 6.64% 29.65% Divi's Laboratories Ltd.
Return on Equity 16.22% 14.64% Remedium Lifecare Ltd.
Return on Assets (TTM) 0.19% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-11.44B $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -78.03% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 0.14 16.18 Remedium Lifecare Ltd.
Enterprise Value $11.62B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.21 15.86 Remedium Lifecare Ltd.
Gross Profit Margin (TTM) 9.53% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $8 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $0.13 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 1.04 0.19 Divi's Laboratories Ltd.

Remedium Lifecare Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

REMLIFE
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare Ltd.-2.78%-5.41%-20.45%-30.00%-65.35%-53.33%
Divi's Laboratories Ltd.0.40%-2.96%-0.35%4.44%1.97%3.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare Ltd.-78.03%-97.95%-55.81%245.45%245.45%245.45%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Remedium Lifecare Ltd. vs Divi's Laboratories Ltd.

MetricREMLIFEDIVISLAB
Market Information
Market Cap i₹308.70M₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i13,880,489253,443
90 Day Avg. Volume i13,121,813283,911
Last Close₹0.35₹6,623.00
52 Week Range₹0.32 - ₹1.80₹5,636.50 - ₹7,071.50
% from 52W High-80.56%-6.34%
All-Time High₹4,547.80 (Jul 03, 2023)₹7,071.50 (Jul 08, 2025)
% from All-Time High-99.99%-6.34%
Growth Metrics
Quarterly Revenue Growth3.43%0.12%
Quarterly Earnings Growth3.86%-0.01%
Financial Health
Profit Margin (TTM) i0.02%0.24%
Operating Margin (TTM) i0.07%0.30%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i1,033.810.58
Cash & Liquidity
Book Value per Share (MRQ)₹1.19₹580.95
Cash per Share (MRQ)₹0.02₹122.95
Operating Cash Flow (TTM) i₹-9,983,884,288₹19.67B
Levered Free Cash Flow (TTM) i₹-9,656,687,616₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Remedium Lifecare Ltd. vs Divi's Laboratories Ltd.

MetricREMLIFE (Mar 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i6.5467.11
Forward P/E iN/A53.75
PEG Ratio i0.034.63
Price to Sales (TTM) i0.1416.18
Price to Book (MRQ) i0.7110.82
Market Capitalization
Market Capitalization i₹308.70M₹1.69T
Enterprise Value i₹11.62B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.2115.86
Enterprise to EBITDA i206.5748.63
Risk & Other Metrics
Beta i1.040.19
Book Value per Share (MRQ) i₹1.19₹580.95

Financial Statements Comparison: Remedium Lifecare Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREMLIFE (2025)DIVISLAB (2025)
Revenue/Sales i4.05B93.25B
Cost of Goods Sold i3.98B38.70B
COGS % of Revenue i98.2%41.5%
Gross Profit i71.16M54.55B
Gross Margin i1.8%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i12.30M25.71B
Operating Margin i0.3%27.6%
EBITDA i120.41M33.19B
EBITDA Margin i3.0%35.6%
Pre-Tax Income i43.84M29.16B
Pre-Tax Income % of Revenue i1.1%31.3%
Income Tax i22.55M7.25B
Income Tax % of Revenue i0.6%7.8%
Net Income (Profit) i21.29M21.91B
Profit Margin i0.5%23.5%

Balance Sheet & Liquidity Metrics

MetricREMLIFE (2025)DIVISLAB (2025)
Cash & Equivalents i2.82M4.15B
Total Current Assets i17.20B100.81B
Total Current Assets % of Revenue i424.5%108.1%
Total Current Liabilities i16.76B14.52B
Total Current Liabilities % of Revenue i413.7%15.6%
Long-Term Debt i020.00M
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i438.91M149.69B
Retained Earnings i35.71M134.00B
Retained Earnings % of Revenue i0.9%143.7%
Property, Plant & Equipment i83,0003.19B

Cash Flow Statement Comparison

MetricREMLIFE (2025)DIVISLAB (2025)
Operating Cash Flow i-16.38B19.67B
Operating Cash Flow % of Revenue i-404.2%21.1%
Capital Expenditures iN/A-14.38B
Free Cash Flow i-11.44B2.15B
FCF Margin i-282.4%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFEDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i881.99M265.47M
Float Shares i382.00M117.72M
% Held by Insiders i15.76%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i84.24%19.31%

Dividend Analysis & Yield Comparison: Remedium Lifecare Ltd. vs Divi's Laboratories Ltd.

MetricREMLIFEDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025